Literature DB >> 4160307

[On the purification and characterization of 2,3-PGase of red blood cells].

G Sauer, D Scholz.   

Abstract

Mesh：

Substances：

Year:  1965        PMID： 4160307

Source DB:  PubMed          Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch        ISSN： 0323-4347


× No keyword cloud information.
  27 in total

1.  Membrane-bound 2,3-diphosphoglycerate phosphatase of human erythrocytes.

Authors:  W Schröter; M Neuvians
Journal:  J Membr Biol       Date:  1970-12       Impact factor: 1.843

2.  FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.

Authors:  Yvonne T Kschonsak; Barbara Vodicska; Kai T Richter; Ingrid Hoffmann
Journal:  Cell Death Differ       Date:  2019-07-08       Impact factor: 15.828

3.  BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression.

Authors:  Hanan S Elsarraj; Yan Hong; Darlene Limback; Ruonan Zhao; Jenna Berger; Stephanie C Bishop; Aria Sabbagh; Linzi Oppenheimer; Haleigh E Harper; Anna Tsimelzon; Shixia Huang; Susan G Hilsenbeck; Dean P Edwards; Joseph Fontes; Fang Fan; Rashna Madan; Ben Fangman; Ashley Ellis; Ossama Tawfik; Diane L Persons; Timothy Fields; Andrew K Godwin; Christy R Hagan; Katherine Swenson-Fields; Cristian Coarfa; Jeffrey Thompson; Fariba Behbod
Journal:  NPJ Breast Cancer       Date:  2020-04-24

4.  Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells.

Authors:  Emarndeena H Cheteh; Victoria Sarne; Sophia Ceder; Julie Bianchi; Martin Augsten; Helene Rundqvist; Lars Egevad; Arne Östman; Klas G Wiman
Journal:  Cell Death Discov       Date:  2020-06-02

5.  [2,3-diphosphoglycerate metabolism and 2,3-diphosphoglycerate mutase deficiency in erythrocytes].

Authors:  W Schröter
Journal:  Blut       Date:  1970-05

Review 6.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

7.  SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.

Authors:  Chi-Neu Tsai; Shu-Chuan Yu; Chao-Wei Lee; Jong-Hwei Su Pang; Chun-Hsin Wu; Sey-En Lin; Yi-Hsiu Chung; Chia-Lung Tsai; Sen-Yung Hsieh; Ming-Chin Yu
Journal:  Oncogene       Date:  2020-05-13       Impact factor: 9.867

8.  Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.

Authors:  Aung Kyi Thar Min; Kosaku Mimura; Shotaro Nakajima; Hirokazu Okayama; Katsuharu Saito; Wataru Sakamoto; Shotaro Fujita; Hisahito Endo; Motonobu Saito; Zenichiro Saze; Tomoyuki Momma; Shinji Ohki; Koji Kono
Journal:  Cancer Immunol Immunother       Date:  2020-07-23       Impact factor: 6.968

9.  An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.

Authors:  Nicolas Piton; Marie-Delphine Lanic; Florent Marguet; Aude Lamy; France Blanchard; Florian Guisier; Mathieu Viennot; Mathieu Salaün; Luc Thiberville; Fabrice Jardin; Jean-Christophe Sabourin; Philippe Ruminy
Journal:  Lab Invest       Date:  2021-01-25       Impact factor: 5.662

10.  Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells.

Authors:  Sho Hangai; Takeshi Kawamura; Yoshitaka Kimura; Ching-Yun Chang; Sana Hibino; Daisuke Yamamoto; Yousuke Nakai; Ryosuke Tateishi; Masanobu Oshima; Hiroko Oshima; Tatsuhiko Kodama; Kyoji Moriya; Kazuhiko Koike; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Nat Immunol       Date:  2021-07-08       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.